These findings confirm that CD8+ T cells consistently mediate part of the ISPS–survival association, even after controlling for stage, tumor size, and sarcopenia, while a direct effect of ISPS beyond the immune pathway remains evident (Table 9). Here, CD8A is linked to sarcopenia.